Belaisch-Allart J, De Mouzon J, Lapousterle C, Mayer M
Department of Obstetrics and Gynaecology, Hôpital A. Béclère, Clamart, France.
Hum Reprod. 1990 Feb;5(2):163-6. doi: 10.1093/oxfordjournals.humrep.a137062.
The necessity of luteal-phase supplementation in an IVF programme is of continuing interest. After ovarian stimulation with clomiphene and human menopausal gonadotrophin (HMG), the beneficial effect of supporting the luteal phase has never been scientifically demonstrated. After ovarian stimulation with GnRH agonist/HMG, the luteal phase seems to be inadequate, but in a previous study we did not find evidence to support the need for oral progesterone supplementation. To evaluate the beneficial effect of human chorionic gonadotrophin (HCG) supplementation, we performed a multicentre, double-blind, randomized study with HCG (193 transfers) against placebo (194 transfers). The ongoing pregnancy rate per transfer cycle was significantly better with HCG (18.7 versus 9.3). This is the first truly objective (randomized) study demonstrating the beneficial effect of supporting the luteal phase in an IVF programme.
在体外受精(IVF)程序中进行黄体期补充的必要性一直备受关注。在用克罗米芬和人绝经期促性腺激素(HMG)进行卵巢刺激后,支持黄体期的有益效果从未得到科学证明。在用促性腺激素释放激素(GnRH)激动剂/HMG进行卵巢刺激后,黄体期似乎不足,但在之前的一项研究中,我们没有找到支持口服孕酮补充必要性的证据。为了评估人绒毛膜促性腺激素(HCG)补充的有益效果,我们进行了一项多中心、双盲、随机研究,将HCG组(193例移植)与安慰剂组(194例移植)进行对比。每个移植周期的持续妊娠率在HCG组显著更高(分别为18.7%和9.3%)。这是第一项真正客观(随机)的研究,证明了在IVF程序中支持黄体期的有益效果。